LES LABORATOIRES SERVIER

In News

Servier Acquires Day One Biopharmaceuticals for $2.5B, Betting on Tovorafenib and the Pediatric Glioma Frontier - Oncodaily

Oncodaily - Mar 13, 2026

Servier to Buy Day One for $2.5 Billion, Expanding Oncology Portfolio - WSJ

WSJ - Mar 06, 2026

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio - Servier

Servier - Mar 06, 2026

Insilico Medicine and Servier collaborate in cancer - bioworld.com

bioworld.com - Jan 05, 2026

France’s Servier Acquires Potential Fragile X Drug in $450 Million Deal - Bloomberg.com

Bloomberg.com - Sep 07, 2025

Servier Buys Fragile X Syndrome Candidate for up to $450M - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Sep 08, 2025

White & Case wins “Impact Case of the Year” award at 2025 LMG Life Sciences EMEA Awards - White & Case LLP

White & Case LLP - Jun 12, 2025

Cellectis (NASDAQ: CLLS) gets partial UCART19 V1 license termination ruling - Stock Titan

Stock Titan - Dec 15, 2025

Servier Inks Insilico Deal To Find Next Cancer Drug Candidates - Citeline News & Insights

Citeline News & Insights - Jan 05, 2026

Cellectis Announces Arbitral Decision in Dispute with Servier - GlobeNewswire

GlobeNewswire - Dec 15, 2025

Arbitration ruling partially terminates Cellectis-Servier license agreement - Investing.com

Investing.com - Dec 15, 2025

Servier reaches settlement with EU over interest on antitrust fine - MLex

MLex - May 15, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment